Cash/Share of BioAmber Inc.
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market customers primarily in the United States and Canada. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company's bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing solutions, PET resins, lubricants, polybutylene succinate, fine chemicals, and food additives. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol and tetrahydrofuran used in elastomers, engineering plastics, shoe soles, spandex, and solvents; succinic acid based polyesters for use in automotive interiors, fibers and non-wovens, food packaging, plastic bags and cups, and organic composite boards; and C6 building block chemicals comprising adipic acid, caprolactam, and hexamethylenediamine used in carpets, engineering plastics, textiles and fibers, films, and polyurethanes. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in September 2010. BioAmber Inc. is headquartered in Montreal, Canada.
|CALA Calithera Biosciences, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||-$27.1M|
|PIRS Pieris Pharmaceuticals, Inc.||NASDAQ > Health Care > Biotechnology: Commercial Physical & Biological Resarch||-$27M|
|EKSO Ekso Bionics Holdings, Inc.||NASDAQ > Capital Goods > Industrial Machinery/Components||-$26.6M|
|LQDT Liquidity Services, Inc.||NASDAQ > Miscellaneous > Business Services||-$26.4M|
|AGLE Aeglea BioTherapeutics, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||-$26.4M|
|TLND Talend S.A.||NASDAQ > Technology > Computer Software: Prepackaged Software||-$26.3M|
|BIOA BioAmber Inc.||NYSE > Basic Industries > Major Chemicals||-$26.2M|
|CHL China Mobile (Hong Kong) Ltd.||NYSE > Public Utilities > Telecommunications Equipment||$42.5B|
|PTR PetroChina Company Limited||NYSE > Energy > Oil & Gas Production||$43.1B|
|VZ Verizon Communications Inc.||NYSE > Public Utilities > Telecommunications Equipment||$44.4B|
|VZA Verizon Communications Inc.||NYSE > Public Utilities > Telecommunications Equipment||$44.4B|
|T AT&T Inc.||NYSE > Public Utilities > Telecommunications Equipment||$48.2B|
|AAPL Apple Inc.||NASDAQ > Technology > Computer Manufacturing||$74.2B|